Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.
The Prostate
View this publicationThe Prostate
View this publicationThe British journal of dermatology
View this publicationJournal of clinical medicine
View this publicationPLoS neglected tropical diseases
View this publicationBMC health services research
View this publicationEuropean journal of nuclear medicine and molecular imaging
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationFrontiers in genetics
View this publicationCell reports methods
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publication